A Study of CS-3150 to Evaluate Efficacy and Safety in Hypertensive Patients with Type 2 Diabetes and Albuminuria
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Esaxerenone (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 31 Mar 2017 Status changed from active, no longer recruiting to completed.
- 14 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Jul 2016 Status changed from not yet recruiting to recruiting.